Transcutaneous energy transfer device

• US 5,350,413 A
• Filed: 07/22/1991
• Issued: 09/27/1994
• Est. Priority Date: 06/21/1990
• Status: Expired due to Term

• Current Assignee: Ottawa Heart Institute Research Corporation
• Original Assignee: University of Ottawa
• Inventors: Miller, John A.
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US07/734,084
• Time in Patent Office: 1,163 Days
• Field of Search: 128/419 HT, 128/419 PS, 128/419 C, 128/ 419 E, 128/419 F, 128/420.5, 128/420.6, 128/804, 128/897-899, 128/930, 128/908, 600/13-18, 336/261, 336/DIG. 2, 336/115, 607/61
• US Class Current: 607/61
• CPC Class Codes: A61N 1/37223 Circuits for electromagnetic coupling
• CPC Class Codes: A61N 1/3787 from an external energy source

Abstract

An improved transcutaneous energy transfer (TET) device comprises a primary winding for placement on or near a skin surface, and a secondary winding for implantation under said skin surface. A field effect transistor (FET) is arranged to switch said primary coil across an external DC power supply. A tuning capacitor is linked to said primary coil whereby said primary coil, when said FET is turned off, will resonate at its natural frequency thereby compensating for drift in component values and reducing power transfer sensitivity to component drift. In an alternative aspect of the invention, a bidirectional communications link is provided for the transfer of data across a boundary layer by infrared signals. A plurality of transmitters are arranged in a circular pattern on one side of the boundary layer, whereas a receiver is positioned within the circular pattern along the opposite side of the boundary layer.

Claims

1. An improved transcutaneous energy transfer (TET) device comprising:

i) a primary winding for placement adjacent to a skin surface, said primary winding being provided with electrical connection means for connecting said primary winding to an external DC power source;

ii) a secondary winding for implantation under said skin surface and coupled with said primary winding to define a transcutaneous transformer;

iii) a field effect transistor (FET) arranged in series with said primary winding to switch said primary winding across said external DC power supply for a predetermined period of time;

iv) means to turn said FET on when voltage across it reaches zero and said primary winding ceases resonating; and

v) a tuning capacitor linked to said primary winding parallel to said FET whereby said primary winding and tuning capacitor, when said FET is turned off after said predetermined period, will resonate at their natural frequency.

2. A device as claimed in claim 1, wherein said windings are made from Litzendrant wire.

3. A device as claimed in claim 1, or 2 wherein a second tuning capacitor comprising a pair of capacitors in series is provided, linked in series with said secondary coil, to stabilize the voltage transfer ratio from the primary to the secondary coil permitting operation without feedback regulation to control for output variations with load.

4. A device as claimed in claim 1, or 2 wherein said secondary winding has a duty cycle of about 0.75, and is tuned to a frequency lower than that of the first, resulting in dual resonance of said transcutaneous transformer.

5. A transcutaneous energy transfer system comprising a transformer having a primary winding and a secondary winding, said primary winding having a generally shallow bell shape to facilitate placement on a skin surface and said secondary winding having a generally shallow bell shape complementary to the shape of said primary winding to facilitate subcutaneous implantation adjacent to said primary winding, said secondary winding being dimensioned to be received within said primary winding to allow for a substantial amount of variation in the relative positions of said primary and secondary windings while minimizing the variation in coupling between said windings.

6. A transformer as described in claim 5, wherein said primary and secondary windings are made of Litzendraht wire.